We are thrilled to be unveiling Relizen at the Integrative Healthcare Symposium to an audience that is both influential and highly knowledgeable in the alternative medicine space.
New York (PRWEB) February 18, 2015
Relizen®, a patented, non-hormonal nutritional supplement for the relief of hot flashes associated with menopause, will be exhibited at the annual Integrative Healthcare Symposium (IHS) at Booth 1104. The annual symposium will be held from February 19, 2015 to February 21, 2015, at the New York Hilton Midtown in New York, NY. This will be Relizen’s first time exhibiting at the conference.
IHS is an annual conference that unites multi-disciplinary healthcare professionals from around the country to discuss integrative medicine. Attendees will discuss and examine new clinical approaches and scientific developments in complementary and alternative medicine.
Relizen first launched in Europe more than 15 years ago, and is now considered one of the leading menopause products in France. Since its United States launch in 2014, Relizen has been recognized by both medical professionals and consumers nationwide for its clinically shown efficacy and safety. The natural supplement was also recently selected as the 2014 SupplySide CPG Editor’s Choice Award winner in the Women’s Health category.
“We are thrilled to be unveiling Relizen at the Integrative Healthcare Symposium to an audience that is both influential and highly knowledgeable in the alternative medicine space,” said Michael Satow, CEO of JDS Therapeutics, LLC. “The show’s focus on new research and treatment opportunities makes Relizen a great fit, and we are looking forward to introducing Relizen to integrative physicians who will be excited to learn about a natural product with substantial clinical data and over 15 years of use in Europe.”
Unlike products that use soy or other phytoestrogens, Relizen is a natural therapy for the relief of hot flashes that has no estrogenic effect and is backed by randomized, placebo-controlled efficacy data. According to a trial published in Climacteric, the official peer-reviewed medical journal of the International Menopause Society, Relizen produced a significant reduction in hot flashes without changing women’s hormone levels compared to placebo.
To learn more about Relizen, please visit http://www.Relizen.com.
About JDS Therapeutics
JDS Therapeutics markets proprietary, high-quality healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. JDS is focused on providing patients with scientifically backed, natural approaches to meeting their healthcare needs, and owns more than 100 issued or pending patents worldwide involving clinically active natural compounds. Relizen is a registered trademark of JDS Therapeutics, LLC.